سعر بوفول 10مجم/مل امبول 2022

Propofol 10 mg/ml intravenous general anaesthetic (Pofol) listed in Egypt by Dong Kook Pharm (Korea) / EIMC.

• Induction of general anaesthesia (patients >= 3 years)DailyMed (US NLM)
• Maintenance of general anaesthesia (patients >= 2 months)DailyMed (US NLM)
• Initiation and maintenance of monitored anaesthesia care (MAC) sedation in adults; sedation of intubated, mechanically ventilated adults in ICUDailyMed (US NLM)

• Clinically important: hypersensitivity reactions, hypotension and/or bradycardia, propofol infusion syndrome; injection-site pain is frequent.International label, equivalent formulation · DailyMed (US NLM)

• Known hypersensitivity to propofol or any component; history of anaphylaxis to eggs, egg products, soybeans or soy products.International label, equivalent formulation · DailyMed (US NLM)

• Fatal and life-threatening anaphylactic and anaphylactoid reactions have been reported.International label, equivalent formulation · DailyMed (US NLM)
• Risk of microbial contamination: strict aseptic technique must be maintained; the emulsion can support microbial growth.International label, equivalent formulation · DailyMed (US NLM)
• Bradycardia, asystole and rarely cardiac arrest; hypotension, especially in elderly, debilitated or ASA-PS III/IV patients.International label, equivalent formulation · DailyMed (US NLM)

• Data from randomised trials, cohort studies and case series over several decades have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes; most exposures were at caesarean delivery.International label, equivalent formulation · DailyMed (US NLM)
• Propofol is present in human milk at variable concentrations; available data have not shown adverse reactions in breastfed infants.International label, equivalent formulation · DailyMed (US NLM)

• Propofol: Positive modulation of GABA-A receptors; short-acting IV hypnotic for induction/maintenance of anaesthesia and sedation.